Investor List:

Top Pharmaceuticals Series B Investors in New York City (37)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Justine Potemkin, Associate at New Enterprise Associates (NEA)
Justine Potemkin
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in New York City
Investors in BioTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Jared Newman, Investor at Canaan Partners
Jared Newman
Canaan Partners·Investor
Sweet spot: $10.0M
Range: $250K - $20.0M
Investors in New York City
Investors in BioTech, Investors in BioTech, Investors in Cloud Infrastructure, Investors in Cloud Infrastructure, Investors in Consumer Health, Investors in Consumer Health, Investors in Consumer Internet, Investors in Consumer Internet, Investors in FinTech, Investors in FinTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of Tim Shannon, General Partner at Canaan Partners
Tim Shannon
Canaan Partners·General Partner
Sweet spot: $10.0M
Range: $250K - $20.0M
Investors in Westport (CT), Investors in New York (NY)
Investors in BioTech, Investors in BioTech, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Photo of James Flynn, Managing Partner at Deerfield Management
James Flynn
Deerfield Management·Managing Partner
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Medical Devices, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Joshua Kennedy-Smith, Managing Director at RTW Investments
Joshua Kennedy-Smith
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Peter Fong, Managing Director at RTW Investments
Peter Fong
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech, Investors in EnergyTech, Investors in Health & Hospital Services, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Paul Lu, Managing Director at RTW Investments
Paul Lu
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals
Photo of Piratip Pratumsuwan, Managing Director at RTW Investments
Piratip Pratumsuwan
RTW Investments·Managing Director
Sweet spot: $25.0M
Range: $10.0M - $50.0M
Investors in New York (NY)
Investors in BioTech, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in New York City (Other Lists), Investors in Pharmaceuticals